Vitamin B12 injection showdown: are two versions the same?
NCT ID NCT07158099
First seen Jun 26, 2026 · Last updated Aug 17, 2026 · Updated 1 time
Summary
This early-stage trial checks whether a new methylconalamin injection works the same as an existing one in 14 healthy adults. Each person gets both versions at different times, and researchers measure drug levels in the blood. The goal is to see if they are bioequivalent, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methylconalamin (a form of vitamin B12)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THERAPEUTIC EQUIVALENCY, HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.